Page last updated: 2024-11-12

edratide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

edratide: based on the complementarity determining region of human 16/6Id; do not confuse with CDR1 protein, human [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16214485
MeSH IDM0505490

Synonyms (14)

Synonym
433922-67-9
unii-38plp07bkc
l-glycyl-l-tyrosyl- l-tyrosyl- l-tryptophyl-l-seryl-l-tryptophyl-l-isoleucyl-l-arginyl-l-glutaminyl-l-prolyl-l-prolyl-l-glycyl-l-lysyl-l-glycyl-l-glutamyl-l-glutamyl-l-tryptophyl-l-isoleucyl-l-glycine
edratide
38plp07bkc ,
edratide [usan:inn:ban]
tv-4710
glycyl-l-tyrosyl-l-tyrosyl-l-tryptophyl-l-seryl-l-tryptophyl-l-isoleucyl-l-arginyl-l-glutaminyl-l-prolyl-l-prolylglycyl-l-lysylglycyl-l-glutamyl-l-glutamyl-l-tryptophyl-l-isoleucylglycine
hcdr1 peptide
edratide [inn]
edratide [usan]
DB15272
Q27256802
DTXSID60195840
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's6 (46.15)29.6817
2010's6 (46.15)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.17 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (15.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]